Document Type

Article

Publication Date

6-30-2022

Comments

This article is the author’s final published version in Advanced Ultrasound in Diagnosis and Therapy, Volume 6, Issue 2, June 2022, Pages 39-47.

The published version is available at https://doi.org/10.37015/AUDT.2022.220017. Copyright © AUDT 2022

Abstract

The use of contrast-enhanced ultrasound (CEUS) has expanded over the past decade to include a variety of diagnostic and therapeutic applications. These include urgent clinical situations that require timely diagnosis and subsequent treatment. With the introduction of microbubble ultrasound contrast agents (UCAs), CEUS provides increased sensitivity and specificity over conventional ultrasound. Within the trauma setting, CEUS benefits include point of care imaging and an ability to monitor perfusion in real-time. Additionally, UCAs are non-nephrotoxic, and can be used when contrast enhanced CT is contraindicated. In this review, we discuss recent advancements of CEUS within trauma settings.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Language

English

Share

COinS